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Introduction 
Diabetes mellitus and prediabetes affect 34 million and 88 million Americans, 
respectively. According to the Center for Disease Control and Prevention (CDC, 2020), diabetes 
mellitus cost the healthcare system an estimated $327 billion in 2017. Stakeholders at a central 
Illinois healthcare institution noted that diagnostic coding for elevated blood glucose (R73) was 
occurring at a significantly higher rate than endocrinology referrals. Following the Lean Six 
Sigma model, a retrospective investigation was conducted to determine the root causes of this 
disproportion. Wait times, provider availability, referral trends, diagnosis prevalence, and 
demographics were among the numerous topics explored. Analysis of the data and trends will 
lead to targeted interventions to improve efficiency, reduce inconsistencies, and ultimately 
patient health outcomes.  
Literature Review 
                The early detection and management of elevated blood glucose levels are fundamental 
to preventing diabetes comorbidities and mortality. Endocrinology referrals allow for more 
specialized care and reduce the long-term consequences of diabetes. Setji et al. (2019) reported 
that patients with diabetes managed by an endocrinologist were found to achieve target blood 
glucose levels sooner and were more likely to have a different medication class prescribed within 
90 days than patients managed by a primary care provider (PCP). Hemoglobin A1C values are 
important in diagnosing and monitoring diabetes as this lab reflects blood glucose over a three-
month period. Achieving target A1C values early can slow the progression of microvascular and 
macrovascular complications over time (ADA, 2020b). Gulliford (2008) found that diagnosis of 
myocardial infarction, cerebrovascular disease, ischemic heart disease, and peripheral nerve 
disorders increased in the six months after diabetes was diagnosed.  
An interdisciplinary team managing diabetes can consist of the PCP, an endocrinologist, 
an ophthalmologist, a cardiologist, a podiatrist, a diabetes educator, a fitness instructor, and a 
dietician (Clement et al., 2018). A referral to endocrinology may be considered for better glucose 
control or after complications of diabetes have developed (Healy et al., 2018). Tzartzas et al. 
(2019) state that the decision to refer a patient to an endocrinologist is subjective and may vary 
from one physician to the next. Tsai et al. (2020) found that elderly diabetic patients who use 
PCPs for the management of diabetes had an increased rate of adverse outcomes compared to 
those with care in a specialized setting.  
Improved communication between the interdisciplinary team may result in better diabetes 
control. Scaioli et al. (2020) surveyed PCPs in 34 different countries and found that there were 
higher rates of communication with specialists when direct modes of communication such as 
phone calls were used as opposed to communication through patient notes or care plans. Mehta 
et al. (2017) surveyed PCPs regarding the use of diabetes screening guidelines and found that, of 
305 physicians surveyed, 38% used guidelines from the American Diabetes Association (ADA) 
and the US Preventative Services Task Force (USPSTF), 33% used ADA only, and 25% used 
USPSTF only. While other countries have established recommendations to guide the PCP in the 
referral process, this literature search did not produce current algorithms or evidence-based 
referral guidelines to the endocrinology specialty in the United States.  
Project Methods 
 The purpose of this project was to investigate the disproportionate number of 
hyperglycemia (R73) diagnosis codes compared to the number of referrals to endocrinology in 
the healthcare organization. Approval for the project was approved by the Institutional Review 
Board (IRB) at the Southern Illinois University Edwardsville in January of 2021. Additionally, 
approval was obtained from the organization’s privacy department. ACT Test, an application 
from the stakeholder organization, was used to obtain de-identified patient data to determine the 
root causes for the disproportion of referrals. Data available from 2018-2020 was included to 
explore appointment wait times, referral rates, referral order status, medications prescribed, and 
demographic differences across family medicine, internal medicine, and endocrinology. The 
following search criteria were used: ages from 18 to 90 years old, R73 diagnosis codes, internal 
medicine and family medicine as referring providers, and endocrinology as the specialty referred 
to. After evaluating the evidence to determine patterns, inconsistencies, and potential root causes, 
evidence-based quality improvement interventions were recommended to improve the referral 
process and increase the referral rate to endocrinology for patients with R73 diagnosis codes.  
Evaluation 
Data on provider availability revealed long wait times for patients with R73 codes. 
Within endocrinology, the third next available appointment was 24.3 days for new patient visits 
and 13.3 days for established patient visits. The average wait time in days for R73 codes in 
family medicine, internal medicine, and endocrinology, was 52, 63, and 90 days, respectively. 
These numbers were much higher than wait days for all codes within these departments. It was 
also found that endocrinology physicians had longer wait times in days but higher patient 
volumes than advanced practice providers (APPs), while the inverse was true for APPs.  
Referral rates for R73 diagnosis codes were also examined across departments. The 
diagnosis code of “other abnormal glucose” warranted the most referrals from family medicine 
(n=15,651), while “hyperglycemia” warranted the most referrals from internal medicine 
(n=5,005). It was also noted that both family medicine and internal medicine had incomplete 
endocrinology referrals for R73 diagnosis codes that needed more information or were being 
held.  
The medications initiated and renewed to treat R73 conditions were evaluated across 
family practice, internal medicine, and endocrinology. Endocrinology prescribed the largest 
assortment of medications (n=15) to combat elevated glucose levels compared to family 
medicine (n=11) and internal medicine (n=11). There were only four mutual medications across 
the three departments. Endocrinology prescribed more complex medications in patient 
encounters (n=42%) compared to family medicine (n=1%) and internal medicine (n=6%). 
Lastly, demographic data identified a gap in referral rate by age group and gender. The 
mean age in years of patients (with R73 as their primary diagnosis code) seen in total patient 
encounters in family medicine was 63, internal medicine was 65, and endocrinology was 53. 
There was also a notable discrepancy in the average age of patients referred to endocrinology 
from family medicine (60.4 years) and internal medicine (54.8 years) compared to the average 
age of patients seen in endocrinology for R73 diagnosis codes (52.7 years). Men in their 50s and 
women in their 60s were the largest demographics seen for R73 codes in endocrinology.  
Impact on Practice 
The immediate impact of the investigation findings brought awareness to the 
inconsistencies across departments. The anticipated long-term impact of this project achieves 
increased endocrinology referral rates and improved health of patients with R73 diagnosis codes. 
To reduce prolonged wait times in endocrinology, a cost-benefit analysis can be conducted to 
weigh provider productivity and cost to determine the impact of additional endocrinology 
providers. Greater provider availability because of increased staffing can reduce patient wait 
times and can lead to improved patient satisfaction, better patient health outcomes, and may 
increase the likelihood of primary care providers referring their patients to endocrinology sooner. 
Referral holds can be addressed by conducting a process analysis to determine the cause of 
referral holds and reduce delays in receiving care. The process analysis can address delays in 
referral order completion by auditing the patient’s insurance information on file for 
completeness, assessing interoffice communication practices, and identifying timeframes for 
each step of the referral process. The demographic differences for R73 diagnosis prevalence and 
endocrinology referral rates can be addressed by creating an algorithm to standardize the R73 
coding and referral process.  
Conclusions 
Through stakeholder interviews and data collection, root causes were identified regarding 
the referral process at the organization. The literature review and data findings demonstrate that, 
while wait times may be increased when patients are referred to endocrinology, diabetes care 
with an endocrinologist is more specific and may lead to better outcomes. This root cause 
investigation highlighted several issues in the endocrinology referral process which will lead to 
further analysis and intervention in the future. By conducting a cost-benefit analysis of providers 
as well as a process analysis of referral delays, the healthcare organization can expect to improve 
provider availability and expedite endocrinology referrals. Additionally, an algorithm to 
standardize coding and referral processes will help to target at-risk populations. These 
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